Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

JANKU, FILIP

One or more keywords matched the following items that are connected to JANKU, FILIP

Item Type	Name
Concept	Clinical Trials, Phase I as Topic
Concept	Clinical Trials, Phase II as Topic
Academic Article	Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center.
Academic Article	Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment.
Academic Article	Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic.
Academic Article	Outcomes of phase II clinical trials with single-agent therapies in advanced/metastatic non-small cell lung cancer published between 2000 and 2009.
Academic Article	Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.
Academic Article	Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program.
Academic Article	Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative.
Academic Article	Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses.
Academic Article	Characteristics and survival of patients with advanced cancer and p53 mutations.
Academic Article	MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors.
Academic Article	Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents.
Academic Article	Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials.
Academic Article	Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.
Academic Article	Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience.
Academic Article	Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials.
Academic Article	Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience.
Academic Article	Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.
Academic Article	Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials
Academic Article	Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults
Academic Article	Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials
Academic Article	Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience.
Academic Article	Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
Academic Article	Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies.
Academic Article	Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit.
Academic Article	Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.
Academic Article	Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients.
Academic Article	Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials.
Academic Article	Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience.
Academic Article	Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
Academic Article	Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
Academic Article	Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.
Academic Article	Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.

Search Criteria

Clinical Trials Phase I as Topic